Inspire Medical Systems (INSP)
(Delayed Data from NYSE)
$237.45 USD
+6.44 (2.79%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $237.47 +0.02 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth D Momentum C VGM
Balance Sheet
Fiscal Year End for Inspire Medical Systems, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 460 | 451 | 214 | 234 | 149 |
Receivables | 90 | 61 | 34 | 25 | 13 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 34 | 12 | 17 | 8 | 6 |
Other Current Assets | 10 | 6 | 3 | 2 | 2 |
Total Current Assets | 594 | 530 | 269 | 270 | 171 |
Net Property & Equipment | 40 | 17 | 8 | 5 | 3 |
Investments & Advances | 9 | 0 | 10 | 0 | 6 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 11 | 11 | 0 | 0 | 0 |
Total Assets | 677 | 565 | 295 | 281 | 181 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 9 | 0 | 0 |
Accounts Payable | 39 | 27 | 12 | 7 | 4 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 39 | 34 | 20 | 14 | 12 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 78 | 61 | 41 | 21 | 17 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 16 | 25 | 25 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 104 | 69 | 66 | 51 | 41 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 917 | 820 | 508 | 467 | 320 |
Retained Earnings | -345 | -324 | -279 | -237 | -180 |
Other Equity | 1 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 573 | 496 | 229 | 230 | 140 |
Total Liabilities & Shareholder's Equity | 677 | 565 | 295 | 281 | 181 |
Total Common Equity | 573 | 496 | 229 | 230 | 140 |
Shares Outstanding | 29.50 | 28.80 | 27.30 | 26.90 | 24.00 |
Book Value Per Share | 19.41 | 17.22 | 8.39 | 8.54 | 5.83 |
Fiscal Year End for Inspire Medical Systems, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 460 | 464 | 467 | 452 |
Receivables | NA | 90 | 71 | 64 | 60 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 34 | 26 | 21 | 16 |
Other Current Assets | NA | 10 | 8 | 9 | 6 |
Total Current Assets | NA | 594 | 570 | 560 | 534 |
Net Property & Equipment | NA | 40 | 32 | 25 | 21 |
Investments & Advances | NA | 9 | 3 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 11 | 12 | 12 | 11 |
Total Assets | NA | 677 | 639 | 618 | 572 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 39 | 40 | 40 | 36 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 39 | 30 | 27 | 23 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 78 | 70 | 67 | 60 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 104 | 95 | 89 | 67 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 917 | 904 | 881 | 844 |
Retained Earnings | NA | -345 | -360 | -352 | -340 |
Other Equity | NA | 1 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 573 | 544 | 529 | 505 |
Total Liabilities & Shareholder's Equity | NA | 677 | 639 | 618 | 572 |
Total Common Equity | 0 | 573 | 544 | 529 | 505 |
Shares Outstanding | 30.30 | 29.50 | 29.30 | 29.30 | 29.10 |
Book Value Per Share | 0.00 | 19.41 | 18.57 | 18.07 | 17.34 |